M. Clinet

638 total citations
18 papers, 525 citations indexed

About

M. Clinet is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, M. Clinet has authored 18 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in M. Clinet's work include Cardiac electrophysiology and arrhythmias (9 papers), Ion channel regulation and function (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). M. Clinet is often cited by papers focused on Cardiac electrophysiology and arrhythmias (9 papers), Ion channel regulation and function (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). M. Clinet collaborates with scholars based in France and Belgium. M. Clinet's co-authors include Pierre Chatelain, J. Lucchetti, Peter Polster, Dino Nisato, J. Broekhuysen, J. P. Gagnol, Magalì Waelbroeck, Jean Camus, Jean Christophe and Patrick Robberecht and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

M. Clinet

17 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Clinet France	12	247	199	180	109	44	18	525
Peter Polster United Kingdom	10	206 0.8×	99 0.5×	267 1.5×	102 0.9×	27 0.6×	18	531
E. Winslow United Kingdom	13	345 1.4×	114 0.6×	330 1.8×	64 0.6×	55 1.3×	43	611
R H Poyser United Kingdom	12	280 1.1×	116 0.6×	245 1.4×	97 0.9×	65 1.5×	32	610
Larry D. Davis United States	14	399 1.6×	132 0.7×	626 3.5×	200 1.8×	21 0.5×	37	964
Christian Lillie Austria	13	172 0.7×	66 0.3×	311 1.7×	83 0.8×	22 0.5×	23	469
Gloria J. Zingaro United States	15	396 1.6×	178 0.9×	287 1.6×	98 0.9×	94 2.1×	30	626
Hiromichi Nakajima United States	15	375 1.5×	146 0.7×	245 1.4×	168 1.5×	33 0.8×	42	788
Helmut Wittneben Germany	5	288 1.2×	138 0.7×	40 0.2×	197 1.8×	13 0.3×	6	498
Theodore P. Broten United States	13	124 0.5×	122 0.6×	195 1.1×	49 0.4×	18 0.4×	21	465
Allen W. Gomoll United States	12	165 0.7×	50 0.3×	257 1.4×	49 0.4×	51 1.2×	38	558

Countries citing papers authored by M. Clinet

Since Specialization

Citations

This map shows the geographic impact of M. Clinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Clinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Clinet more than expected).

Fields of papers citing papers by M. Clinet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Clinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Clinet. The network helps show where M. Clinet may publish in the future.

Co-authorship network of co-authors of M. Clinet

This figure shows the co-authorship network connecting the top 25 collaborators of M. Clinet. A scholar is included among the top collaborators of M. Clinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Clinet. M. Clinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Clinet, M., et al.. (2004). SR 33557, a novel calcium-antagonist: interaction with [3H]-(�)-nitrendipine and [3H]-(?)-desmethoxy-verapamil binding sites in cerebral membranes. Naunyn-Schmiedeberg s Archives of Pharmacology. 339-339(1-2). 31–36.

Chatelain, Pierre, et al.. (1995). Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the β‐adrenoceptor and adenylate cyclase in rat heart. British Journal of Pharmacology. 116(3). 1949–1956. 63 indexed citations

Lucchetti, J., et al.. (1994). ChemInform Abstract: Novel Heterocyclic Analogues of the New Potent Class of Calcium Entry Blockers: 1‐((4‐(Aminoalkoxy)phenyl)sulfonyl)indolizines.. ChemInform. 25(10). 3 indexed citations

Chatelain, Pierre, et al.. (1994). Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane. European Journal of Pharmacology Molecular Pharmacology. 267(2). 151–160. 6 indexed citations

Lucchetti, J., et al.. (1993). Novel heterocyclic analogs of the new potent class of calcium entry blockers: 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines. Journal of Medicinal Chemistry. 36(10). 1425–1433. 111 indexed citations

Chatelain, Pierre, M. Clinet, Peter Polster, B. Christophe, & A Manning. (1993). In vitro characterization of a novel Ca2+ entry blocker: SR 33805. European Journal of Pharmacology Molecular Pharmacology. 246(3). 181–193. 13 indexed citations

Lucchetti, J., et al.. (1992). A novel class of calcium-entry blockers: the 1-[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines. Journal of Medicinal Chemistry. 35(6). 981–988. 117 indexed citations

Chatelain, Pierre, et al.. (1992). Prevention of calcium overload and down-regulation of calcium channels in rat heart by SR 33557, a novel calcium entry blocker.. PubMed. 3(2). 117–23. 14 indexed citations

Chatelain, Pierre, et al.. (1991). Characterization of the slow calcium channel binding sites for [3H]SR 33557 in rat heart sarcolemmal membranes.. Molecular Pharmacology. 39(1). 64–71. 15 indexed citations

10.

Clinet, M., et al.. (1990). SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.. Journal of Pharmacology and Experimental Therapeutics. 255(2). 600–607. 25 indexed citations

11.

Clinet, M., et al.. (1990). Characterization of [3H]-SR 33557 binding sites in rat heart sarcolemma. Journal of Molecular and Cellular Cardiology. 22. S12–S12. 1 indexed citations

12.

Clinet, M., et al.. (1986). Allosteric Modulation of [3H]Nitrendipine Binding to Cardiac and Cerebral Cortex Membranes by Amiodarone. Journal of Cardiovascular Pharmacology. 8(5). 1051–1057. 19 indexed citations

13.

Robberecht, Patrick, et al.. (1985). Uncoupling between beta-adrenoceptors and adenylate cyclase in dog ischemic myocardium. Naunyn-Schmiedeberg s Archives of Pharmacology. 331(1). 71–75. 33 indexed citations

14.

Gagnol, J. P., et al.. (1985). Amiodarone*. Drugs. 29(Supplement 3). 1–10. 22 indexed citations

15.

Clinet, M., et al.. (1984). Inhibition by amiodarone of [3H] nitrendipine binding to cerebral cortex membranes. Journal of Molecular and Cellular Cardiology. 16. 17–17. 1 indexed citations

16.

Clinet, M., et al.. (1983). Cardiac β-adrenoceptor modulation by amiodarone. Biochemical Pharmacology. 32(17). 2473–2477. 52 indexed citations

17.

Broekhuysen, J., et al.. (1972). Action of amiodarone on guinea pig heart sodium and potassium activated adenosine triphosphatase. Biochemical Pharmacology. 21(22). 2951–2960. 27 indexed citations

18.

Clinet, M. & J. Broekhuysen. (1972). Action of amiodarone on rabbit muscle calcium-dependent adenosine triphosphatase. Biochemical Pharmacology. 21(22). 2961–2965. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact